ABSCIENCES (EPA:AB) AB Science announces the publication of an article in the world-renowned journal Science that confirms potential of masitinib as a treatment of Covid-19 with anti-viral activity against SARS-CoV-2 and all tested variants of concern
Transparency directive : regulatory news
20/07/2021 18:08